Objective Current evidence on the effectiveness of SARS-CoV-2 prophylaxis is inconclusive.
We aimed to systematically evaluate published studies on repurposed drugs for the …

Background India has seen more than 43 million confirmed cases of COVID-19 as of April
2022, with a recovery rate of 98.8%, resulting in a large section of the population including …

In the era of evidence-based medicine, real-world evidence (RWE) studies have opened
avenues to utilize real-world data (RWD) effectively for improving clinical decision-making …

Background Health care workers (HCW) are among the highest risk groups for acquisition of
COVID-19 because of occupational exposures. The WHIP COVID-19 Study aimed to …

Background Hydroxychloroquine had attracted significant attention in the initial phases of
the COVID-19 pandemic but current recommendations do not support its use. However, the …

Chloroquine was once thought to be a promising treatment for COVID-19 but it quickly failed
due to its inefficiency and association with increased mortality. Further, comorbidities such …

To date, the COVID-19 pandemic has resulted in more than 200 million cases of SARS-CoV-
2 infection and more than four million deaths world-wide. 1 Although novel COVID-19 …

Healthcare workers (HCWs) and frontline workers were recommended hydroxychloroquine
(HCQ) 400 mg twice a day on day 1, followed by 400 mg once weekly for the next 7 weeks …

Objectives: Comparative study of Ashwagandha (Withania somnifera; WS) and
hydroxychloroquine (HCQ) for chemoprophylaxis against COVID-19 in actively engaged …

Statistics evolved as a science in an era when the amount of data available was small and
efforts were on to extract maximum information from them. Are the techniques developed …